ORAL CONTRACEPTIVES IN HqMOPHILIA

A controlled trial of an oral contraceptive in the treatment of 18 boys with haemophilia is reported. During the treatment with combined oestrogens and progesterone we found a reduction in bleedings of the skin and joints, associated with a minor shortening of coagulation time in glass and plastic as well as a decrease in kaolin‐cephalin time. Correspondingly, there was a significant increase in fibrinogen and factor II + VII levels. The treatment did not affect the number of days in bed, haematuria, epistaxis or muscular bleeding. ‐ Because of this rather negligible effect and since all patients developed severe side effects (gynaecomastia and pubic hair), we do not recommend this treatment in the general management of haemophilia.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

ORAL CONTRACEPTIVES IN HqMOPHILIA

Cited by 2 publications

References 0 publications

Contraceptive use in the chronically Ill adolescent female. Part II

Contraceptive use in the chronically Ill adolescent female. Part II

Controlled Trial of Oral Contraceptives in Haemophilia

Contact Info

Product

Resources

About